MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours

BACKGROUND: MYC is amplified in approximately 15% of breast cancers (BCs) and is associated with poor outcome. c-MYC protein is multi-faceted and participates in many aspects of cellular function and is linked with therapeutic response in BCs. We hypothesised that the functional role of c-MYC differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Andrew R, Aleskandarany, Mohammed A, Agarwal, Devika, Elsheikh, Somaia, Nolan, Christopher C, Diez-Rodriguez, Maria, Macmillan, R Douglas, Ball, Graham R, Caldas, Carlos, Madhusudan, Srinivasan, Ellis, Ian O, Rakha, Emad A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984797/
https://www.ncbi.nlm.nih.gov/pubmed/26954716
http://dx.doi.org/10.1038/bjc.2016.46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984797/
https://www.ncbi.nlm.nih.gov/pubmed/26954716
http://dx.doi.org/10.1038/bjc.2016.46

Ejemplares similares